Showing results (511-520 of 597) with videos related to

Sort By:
Pageof 60
European Heart Journal|April 4, 2017
The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction OutcomesMaria Grazia Bongiorni, Charles Kennergren, Christian Butter, et al.
Heart Rhythm|August 29, 2024
Left ventricular electrical delay predicts volumetric response to leadless cardiac resynchronization therapyNadeev Wijesuriya, Vishal Mehta, Felicity De Vere, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 12, 2022
Non-invasive localization of post-infarct ventricular tachycardia exit sites to guide ablation planning: a computational deep learning platform utilizing the 12-lead electrocardiogram and intracardiac electrograms from implanted devicesSofia Monaci, Shuang Qian, Karli Gillette, et al.
JACC. Cardiovascular Imaging|February 22, 2016
Contribution of PET Imaging to the Diagnosis of Septic Embolism in Patients With Pacing Lead EndocarditisSana Amraoui, Ghoufrane Tlili, Manav Sohal, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 8, 2023
Arrhythmogenic vulnerability of re-entrant pathways in post-infarct ventricular tachycardia assessed by advanced computational modellingPranav Bhagirath, Fernando O Campos, Pieter Postema, et al.
Pharmaceutical Research|March 1, 2015
Role of Self-Association and Supersaturation in Oral Absorption of a Poorly Soluble Weakly Basic DrugAjit S Narang, Sherif Badawy, Qingmei Ye, et al.
Heart Rhythm O2|May 2, 2022
Effect of scar and pacing location on repolarization in a porcine myocardial infarction modelMark K Elliott, Caroline Mendonca Costa, John Whitaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignanciesL A Hammond, J R Eckardt, S D Baker, et al.
Pageof 60